Skip to main content
. 2025 Jan 2;15:4. doi: 10.1038/s41598-024-84077-w

Fig. 1.

Fig. 1

Outcome of the IMM cases. (A) Outcome of IMM Case 1, (B) Outcome of IMM Case 2. *Steroids were administered as part of gene therapy treatment. BID twice daily, BiPAP bilevel positive airway pressure, BNP brain natriuretic peptide, BUN blood urea nitrogen, CK creatine kinase, cMRI cardiac magnetic resonance imaging, CXR chest X-ray, ECG electrocardiogram, ECHO echocardiogram, EDVi end-diastolic volume, ELISpot enzyme-linked immunosorbent spot, ESR erythrocyte sedimentation rate, Hct hematocrit, Hg hemoglobin, IMM immune-mediated myositis, INR international normalized ratio, IVIG intravenous immunoglobulin, LFT liver function test, MRI magnetic resonance imaging, NG nasogastric tube, NSAA North Star Ambulatory Assessment, PTT partial thromboplastin time, Strep Streptococcus pyogenes, WBC white blood cell.